Intralytix's patent strategy is based on a multipronged approach, which provides broad and strong protection ranging from protecting specific bacteriophages that serve as the cornerstone of various Company products to methods and applications of those bacteriophages in various settings. At the present time, Intralytix, Inc. has several issued patents and several pending patent applications. The following list includes selected patents and is provided to satisfy the requirements of 35 U.S.C. § 287(a).
U.S. Patent No. 7,507,571; 8,685,697
U.S. Patent No. 7,625,741; 7,635,584; 7,625,556
U.S. Patent No. 7,674,467; 8,685,696
U.S. Patent Application No. 15/002,708; International Patent Application No. PCT/US2016/014308; Bangladesh Patent Application No. 17/2016. Other patent applications pending.
U.S. Patent No. 7,625,741; 7,635,584; 7,625,556
U.S. Patent No. 7,625,741; 7,635,584; 7,625,556
U.S. Patent No. 7,674,467; 8,685,696
U.S. Patent No. 7,507,571; 8,685,697
Phagebiotix™/Dietary Supplements/Nutraceutical Products
U.S. Patent Application No. 15/002,708; International Patent Application No. PCT/US2016/014308; Bangladesh Patent Application No. 17/2016. Other patent applications pending.
U.S. Patent No. 7,625,739; 7,625,740
Pre-Harvest Interventions
U.S. Patent No. 7,625,741; 7,635,584; 7,625,556